Table 1.
Genotype | COM (n=189) | Control (n=119) | P-valuea) | Allele frequency |
|||
---|---|---|---|---|---|---|---|
Allele | COM | Control | P-valuea) | ||||
IL-1RA VNTR | <0.01 | ||||||
11 | 133 (70.4) | 60 (50.4) | 1 | 0.81 | 0.71 | ||
12 | 38 (20.1) | 40 (33.6) | 2 | 0.16 | 0.26 | 0.005 | |
13 | 5 (2.7) | 8 (6.7) | 0.006 | 3 | 0.03 | 0.03 | |
22 | 10 (5.3) | 11 (9.3) | |||||
23 | 1 (0.5) | 0 | |||||
33 | 2 (1.0) | 0 | |||||
IL-1β TaqI | |||||||
11 | 110 (58.2) | 61 (51.3) | 1 | 0.77 | 0.73 | 0.285 | |
12 | 70 (37.1) | 51 (42.8) | 0.487 | 2 | 0.23 | 0.27 | |
22 | 9 (4.7) | 7 (5.9) |
Values are presented as number (%).
IL-1RA, interleukin-1 receptor antagonist; VNTR, variable number tandem repeat; IL-1β, interleukin-1 beta; COM, chronic otitis media.
P-value (chi-square) of the difference in genotype and allele frequency distribution.